Clinical trial • Phase I • Oncology
PM534 for Advanced solid tumors
Phase I trial of PM534 for Advanced solid tumors. 145 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 26-04-2024
- First CTIS Authorization Date
- 30-04-2024
Trial design
Phase I trial across 3 sites in Spain.
- Target Sample Size
- 145
Recruitment
- Planned Sample Size
- 145
- Recruitment Window Months
- 65
Geography
- Total Number Of Sites
- 3
- Total Number Of Participants
- 145
Spain
- Earliest CTIS Part Ii Submission Date
- 02-04-2024
- Latest Decision Or Authorization Date
- 06-04-2026
- Processing Time Days
- 734
- Number Of Sites
- 3
- Number Of Participants
- 145
Sites
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- START Madrid-FJD
- Contact Person Name
- Victor Moreno García
- Contact Person Email
- victor.moreno@startmadrid.com
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- START Madrid-HM CIOCC
- Contact Person Name
- Irene Moreno
- Contact Person Email
- irene.moreno@startmadrid.com
- Site Name
- Hospital Hm Nou Delfos
- Department Name
- START Barcelona
- Contact Person Name
- Tatiana Hernandez Guerrero
- Contact Person Email
- Tatiana.hernandez@start-barcelona.com
Sponsor
Primary sponsor
- Full Name
- Pharma Mar S.A.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Spain
Investigational products
- Investigational Product Name
- PM534
Related trials
Other published trials that may interest you.